HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Decreased neutrophil bactericidal activity in acute leukemia of childhood.

Abstract
Neutrophil (PMN) bactericidal activity, phagocytosis, and nitroblue tetrazolium (NBT) reduction were evaluated in 18 children with untreated or relapsing acute leukemia and 20 children in hematologic remission. Half of the patients in relapse demonstrated abnormal PMN bactericidal activity, while remission patients had essentially normal PMN bactericidal activity. Phagocytosis of Staphylococcus aureus was normal in relapse and remission subjects. NBT reduction by PMN's of leukemic patients was significantly lower than that of controls, but there was no correlation between decreased NBT-reductase activity and decreased bactericidal power. Six patients in remission had received intensive chemotherapy for more than 4 years, and all demonstrated normal PMN functions. Among relapse patients with abnormal PMN bactericidal activity 63% eventually developed severe bacterial infections. By comparison, 20% of the relapse patients with normal PMN bactericidal activity subsequently developed severe infections. The PMN dysfunction observed in relapse patients suggests that abnormal PMN bactericidal activity may contribute the increased susceptibility to bacterial infections during leukemic relapse.
AuthorsJ R Humbert, J J Hutter Jr, C H Thoren, P A DeArmey
JournalCancer (Cancer) Vol. 37 Issue 5 Pg. 2194-200 (May 1976) ISSN: 0008-543X [Print] United States
PMID1260709 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Nitroblue Tetrazolium
Topics
  • Bacterial Infections (complications, immunology)
  • Blood Bactericidal Activity
  • Child
  • Humans
  • Leukemia (complications, immunology)
  • Neoplasm Recurrence, Local
  • Neutrophils (immunology)
  • Nitroblue Tetrazolium
  • Phagocytosis
  • Remission, Spontaneous
  • Staphylococcus aureus

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: